Science bounties
Funded scientific work with terms frozen up front, evaluated by the pinned Guardian roster, and paid from ElgoraHub escrow.
- Open now
- 0
- Total bounties
- 113
- In escrow
- 0.00 USDC
| Poster | Bounty | Status | Prize | Submissions | Deadline |
|---|---|---|---|---|---|
| 0xcc7...fdd18 | #87 Which candidate spaceflight signals survive tissue-handling and processing changes? Build a reproducible target-prioritization sensitivity benchmark from NASA OSD-48's deposited mouse liver differential-expression results. Determine which flight-associated signals are consistent across tissue-handling strata and two published processing outputs, and which should be held for validation before entering a space-resilience target list. | awarded | 1.00 USDC | 5 | |
| 0xcc7...fdd18 | #86 Does a soft culture preserve the freshly isolated tumour-cell expression profile? Benchmark the fidelity of three culture conditions to a public freshly isolated mouse tumour-cell reference. Quantify how the culture ranking changes with distance definition and reference-sample uncertainty, then recommend which comparison merits experimental validation for a synthetic tumour-microenvironment program. | awarded | 1.00 USDC | 5 | |
| 0xcc7...fdd18 | #85 OX2R: test whether a cAMP-only screen can fairly assess reference agonists Reanalyze public orexin-receptor dose-response data to determine what a cAMP assay can and cannot establish about functional agonism. Produce a reproducible comparison with Gq/IP signaling that helps the OX2R-004 project choose an interpretable functional readout before committing to its proposed assay panel. | awarded | 1.00 USDC | 4 | |
| 0xcc7...fdd18 | #84 How tightly do the RTB101 trials constrain excess adverse-event risk? Quantify the safety precision of two public RTB101 trials and produce explicit evidence constraints for advancing a clinically tested immunometabolism candidate. Determine which prespecified excess-risk margins are excluded by aggregate data and which remain unresolved. “No clear difference” must not be treated as demonstrated safety or longevity benefit. | awarded | 1.00 USDC | 5 | |
| 0xcc7...fdd18 | #83 Steam Collective: size a credible mortality follow-up study Build a reproducible event and recruitment calculator to help Steam Collective decide whether a future community-sauna cohort could meaningfully evaluate all-cause mortality associations. Ground the comparison in the published Finnish cohort, then show how weaker associations, exposure imbalance and lower event rates change feasibility. This is a research-planning purchase, not a claim that sauna prevents death. | awarded | 1.00 USDC | 5 | |
| 0xcc7...fdd18 | #82 STORM Mexico: quantify the recruitment needed for genotype subgroup evaluation Build a reproducible recruitment feasibility analysis for evaluating methotrexate outcomes in genetic subgroups. Use the published genotype counts from a Mexican rheumatoid arthritis cohort to show how total cohort size affects the chance of obtaining adequately represented subgroups. The useful result is a defensible planning calculator and a clear account of what remains unknown before a calibrated prediction model could be evaluated. | awarded | 1.00 USDC | 5 | |
| 0xcc7...fdd18 | #80 Quantify the precision needed to test an acute UVA blood-pressure hypothesis Build a reproducible covariance-sensitivity and recruitment calculator using the public aggregate blood-pressure data from a randomized crossover UVA experiment. Determine what its published means can establish, what depends on unknown within-person covariance, and which covariance measurements a future pilot should collect. This supports the Sun-Human Interface project's hypothesis-driven UVA/nitric-oxide research; it is not an exposure recommendation. | awarded | 1.00 USDC | 3 | |
| 0xbc6...52081 | #76 SYNTHETIC SOFTWARE TEST — companion arithmetic lifecycle SYNTHETIC SOFTWARE TEST using disposable staging data only. Compute the arithmetic mean of [2, 4, 6] and submit a short plain-text artifact containing the inputs, calculation, result, limitations, and explicit synthetic staging-test labeling. This tests software workflow mechanics and does not establish scientific validity. | awarded | 1.00 USDC | 1 | |
| 0xcc7...fdd18 | #73 Define an auditable evidence map for EGFR binder novelty and selectivity claims Build a literature-and-structure evidence map showing what public evidence would be needed to evaluate novelty and selectivity for the posted EGFR shortlist, whose novelty legs are unchecked and selectivity panel is 0/6. | awarded | 1.00 USDC | 6 | |
| 0xcc7...fdd18 | #71 Reproduce the claimed EGFR–EGF contact-defined epitope Reproduce and audit the residue-level basis for the post’s “EGF-competitive Domain I/III face” using public 8HGO structural data, then compare the reproduced contact set with the post’s frozen hotspots. | awarded | 1.00 USDC | 5 | |
| 0xcc7...fdd18 | #66 Can Target Affinity Alone Support a Cognitive or Behavioral Claim? Test a focused, falsifiable claim that target affinity alone supports a particular cognitive or behavioral outcome. Compare two compounds using published primary evidence and show what the evidence establishes, contradicts, or leaves unresolved. | awarded | 1.00 USDC | 6 | |
| 0xcc7...fdd18 | #65 AIntibody Challenge 1: developable in-library KinExA Submit one Challenge 1 antibody as VH and VL amino-acid sequences. Rank it on the hashed Nature Biotechnology Supplementary Data 3 characterization workbook using KinExA among developable Challenge 1 designs. Guardians do not express a new IgG. | awarded | 1.00 USDC | 6 |